Archives
-
Quinolone–Coumarin Hybrids Against T. gondii
2026-08-27
A 2024 Acta Parasitologica study evaluated 12 quinolone–coumarin hybrids derived from fluoroquinolones and novobiocin against intracellular Toxoplasma gondii. Several hybrids and novobiocin reduced infection, parasite proliferation, and plaque formation in vitro while preserving host-cell viability, providing an early framework for antiparasitic lead selection.
-
CCK-8 for Mechanism-Aware Cancer Research
2026-08-27
Cell Counting Kit-8 (CCK-8) converts viable-cell dehydrogenase activity into a convenient soluble formazan signal. This mechanism-aware guide shows how cck8 can support interpretation of PDIA1-targeted cancer studies while separating proliferation effects from metabolic assay artifacts.
-
Cell Counting Kit-8 (CCK-8) for Viability
2026-08-26
Cell Counting Kit-8 (CCK-8) uses WST-8 conversion to quantify viable-cell-associated metabolic activity with a water-soluble formazan readout. The cck8 workflow is useful for proliferation and cytotoxicity comparisons, but its signal requires biological and chemical controls before it is interpreted as cell number or mechanism.
-
How Propranolol Modulates Essential Tremor
2026-08-26
A prospective TMS study separates the cortical circuit signatures associated with primidone and propranolol in essential tremor. The findings link propranolol-related tremor reduction to lower corticospinal excitability and enhanced short afferent inhibition, supporting a central noradrenergic–GABAergic contribution alongside peripheral beta-adrenergic actions.
-
Phosphotungstic Acid Negative Stain Solution Workflow
2026-08-25
Turnaround-ready negative staining helps researchers assess virion morphology, macromolecular assemblies, and sample heterogeneity before committing to higher-resolution workflows. This guide connects a 2% phosphotungstic acid reagent with glycan-focused coronavirus research while separating what electron microscopy can show from what functional assays must establish.
-
Protecting Signaling Fidelity in TB Protein Studies
2026-08-25
Mechanistic studies of macrophage immunity depend on preserving fragile protein abundance, interactions, and phosphorylation states. This thought-leadership article connects the ZDHHC2–RAF–ERK axis in tuberculosis research with practical sample-protection strategy, showing how an EDTA-free Protease Inhibitor Cocktail can improve translational assay confidence without being mistaken for a biological intervention.
-
Zosuquidar (LY335979) in P-gp MDR Workflows
2026-08-24
Zosuquidar (LY335979) 3HCl provides a selective way to test whether P-glycoprotein drives chemotherapy resistance rather than merely increasing cytotoxic exposure. This guide converts that mechanism into reproducible cell-based sensitization, intracellular accumulation, and translational pharmacokinetic workflows.
-
CCK-8 Antagonism of Electroacupuncture Analgesia
2026-08-24
The 1986 reference study showed that centrally administered CCK-8 dose-dependently antagonized electroacupuncture analgesia without changing baseline nociception, while CCK-8 antiserum delayed or reversed electroacupuncture tolerance. Its selective interaction with opioid-linked analgesia positioned endogenous CCK-8 as a candidate anti-opioid signal in the central nervous system.
-
ORM2–ZG16 Axis in Pancreatic Fibrosis
2026-08-23
A February 2026 Pancreatology study identifies ORM2 as an endogenous suppressor of chronic pancreatitis-associated fibrosis and links its activity to ZG16-dependent control of autophagy in pancreatic stellate cells. Genetic loss- and gain-of-function experiments, together with cellular flux assays, provide a mechanistic framework for evaluating antifibrotic interventions in caerulein-induced pancreatic injury.
-
Annexin V-FITC/7-AAD Apoptosis Kit Guide
2026-08-22
The Annexin V-FITC/7-AAD Apoptosis Kit provides a rapid dual-fluorescence readout for distinguishing viable-like, apoptotic-like, and necrotic-like cell populations in cell viability and cytotoxicity workflows. It is intended for fluorescence microscopy or flow cytometry, not for pathway elucidation or as a standalone confirmation of the molecular cause of cell death.
-
Catalpol and the Sirt6–ERα–FasL Axis in Osteoporosis
2026-08-22
This study identifies a bone-protective mechanism for Catalpol in estrogen deficiency: promotion of osteoclast apoptosis through Sirt6-dependent ERα deacetylation and FasL signaling. Its combination of an ovariectomized rat osteoporosis animal model, RANKL-induced osteoclast assays, and Sirt6 knockdown provides a useful framework for mechanistic replication and translational interpretation.
-
Recombinant Human Growth Hormone: Axis to Assay
2026-08-21
Recombinant Human Growth Hormone can function as more than a proliferation stimulus: it enables causal analysis of growth hormone receptor activation, IGFBP2, THBS1, and IGF-1 signaling. This article presents a differentiated assay strategy grounded in recent human chondrocyte research and practical reagent-quality considerations.
-
ORM2–ZG16 Autophagy Axis in Pancreatic Fibrosis
2026-08-20
A 2026 Pancreatology study identifies ORM2 as an endogenous inhibitor of chronic pancreatitis-associated fibrosis and links its activity to ZG16-dependent control of autophagy in pancreatic stellate cells. Genetic loss- and gain-of-function experiments suggest that the ORM2–ZG16 interaction is mechanistically important, while the model design provides a useful framework for studying antifibrotic interventions.
-
2X Taq PCR Master Mix: Mechanism & Workflow
2026-08-20
2X Taq PCR Master Mix is a ready-to-use molecular biology reagent for routine DNA amplification, genotyping, cloning, and sequence analysis. Its recombinant Taq enzyme supports 3′ adenine overhang formation, while the integrated loading dye enables direct gel loading, as described in the product information.
-
Self-Amplifying RNA Vaccines for Influenza Dose Sparing
2026-08-19
Huang and colleagues compared optimized influenza mRNA, self-amplifying RNA, and circular RNA vaccine strategies across influenza A and B subtypes. In mice, low-dose trivalent self-amplifying RNA produced durable antibody responses and complete protection against influenza B challenge, addressing a major immunogenicity limitation observed with conventional mRNA vaccination.